Feed 1513.HK
15
Livzon Pharmaceutical Group Inc.
1513.HK · HKSE
$25.92 -1.44% (-$0.38)
1M +9.71%
Market Cap $28.8B
P/E Ratio 13.16x
Div. Yield 6.24%
ROE 15.35%
Bulios Fair Price
$137.98
432.3% upside
Τρέχουσα τιμή
$25.92
Υποτιμημένο Δίκαιη αξία Υπερτιμημένο
Valuation
75 /100
Cheap P/E 13.16x
EV/EBITDA 7.40x
P/S 2.38x
Growth
15 /100
Declining EPS growth 2.70%
Rev. growth 2.79%
FCF growth 11.46%
Profitability
85 /100
Strong Gross margin 65.92%
Net margin 18.05%
Op. margin 24.91%
Quality
37 /100
Average ROIC 11.20%
ROE 15.35%
ROA 8.15%
Debt
92 /100
Low Debt/Equity 0.33x
Current ratio 2.25x
Int. coverage 47.59x
Stability
75 /100
Stable Beta 0.24x
Rev. volatility 1.90%
EPS volatility 4.01%
Ρωτήστε το StockBot για 1513.HK
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Daping Liu
Employees
8,878
Headquarters
Zhuhai
Επερχόμενα γεγονότα
22 ΑΥΓ
Earnings
Upcoming earnings report